Eugen Steiner
InvestorBoard director at NephroGenex
Stockholm, Sweden
Writes $100K – $5M checks · typically $1.5M
Find your path to Eugen
153 people in our graph share verified history with Eugen — schools, employers, funds. One of them is your warm intro.
Jessica SchultzunlockedEugen: together at Royal Swedish Academy of Engineering Sciences (2021–2026)
×5Eugen: together at Karolinska Institutet
×2Eugen: together at KTH Royal Institute of Technology
×3Eugen: together at Weizmann Institute of Science
About
Venture partner since 1997 who serves as CEO of several portfolio companies. He holds an MD and PhD in clinical pharmacology from Karolinska Institute.
Board director at NephroGenex
Intro paths
→
In turn, Eugen can intro founders to NephroGenex's investors below.
NephroGenex's investors · 1
Experience
- BioArcticChair of the Board of Directorscurrent2023 — presentStockholm, Stockholm County, Sweden
- BioArcticDirectorcurrent2017 — presentGreater Stockholm Metropolitan Area
- Royal Swedish Academy of Engineering SciencesChair Avdelning Bioteknik och Lifescience/Division Biotechnology and Lifesciencecurrent2024 — presentStockholm, Stockholm County, Sweden
- Royal Swedish Academy of Engineering SciencesFellow of the Royal Swedish Academy of Engineering Sciences (IVA)current2021 — presentStockholm, Stockholm County, Sweden
- Royal Swedish Academy of Engineering SciencesVice Chairman Division Biotechnology2021 — 2023
- Empros PharmaChair of the Board of Directorscurrent2020 — presentStockholm, Stockholm County, Sweden
- INBOX CAPITAL ABDirectorcurrent2015 — presentGreater Stockholm Metropolitan Area
- Stockholm School of EntrepreneurshipDirectorcurrent2005 — presentGreater Stockholm Metropolitan Area
- Karolinska InstitutetVisiting Lecturercurrent2001 — presentStockholm
- KTH Royal Institute of TechnologyVisiting Lecturercurrent2003 — presentStockholm, Stockholm County, Sweden
- Setraco ABOwnercurrent1984 — present
- EpiEndo PharmaceuticalsDirector2022 — 2024Iceland
- HealthCapVenture Partner1997 — 2023
- A3P BiomedicalBoard Member2021 — 2023Stockholm, Stockholm County, Sweden
- Spago Nanomedical ABChair of the Board of Directors2019 — 2023Lund, Skåne County, Sweden
- Karolinska Institutet InnovationsDirector2018 — 2022Greater Stockholm Metropolitan Area
- Karolinska Institutet HoldingDirector2017 — 2022Greater Stockholm Metropolitan Area
- VinnovaExternal assesor2014 — 2021Greater Stockholm Metropolitan Area
- DoctrinDeputy Director2017 — 2021Greater Stockholm Metropolitan Area
- APL (Apotek Produktion & Laboratorier AB)Director2010 — 2021
- SkandiaMedical scientific advisor2016 — 2020Stockholm, Stockholm County, Sweden
- Forska!SverigeDirector2010 — 2020Greater Stockholm Metropolitan Area
- NVC Holding ABCEO2009 — 2018
- Glionova ABCEO2014 — 2018
- MD International ABDirector2016 — 2017
- Globen Ögonklinik ABChair of the Board of Directors2013 — 2017Greater Stockholm Metropolitan Area
- NephrogenexDirector2007 — 2017Raleigh-Durham-Chapel Hill Area
- Alba Therapeutics Inc.Director2006 — 2017
- Biostratum Inc.Chairman, CEO2005 — 2016Raleigh-Durham-Chapel Hill Area
- HANZA GroupDirector2010 — 2015Greater Stockholm Metropolitan Area
- Nordic Vision ClinicsCEO2012 — 2015Oslo, Oslo, Norway
- Insamlingsstiftelsen för MS ForskningBoard Member2009 — 2013Stockholm, Stockholm County, Sweden
- Praktikertjänst ABDirector2006 — 2012
- Creative Peptides (Cebix since 2008)CEO2002 — 2007
- Global GenomicsChair of the Board of Directors2001 — 2005
- Affibody ABCEO2000 — 2002
- Biolipox (Orexo since 2007)Chair of the Board of Directors2000 — 2002
- Visual Bioinformatics (Affibody since 2001)CEO2000 — 2001
- Eurona (Gemini Genomics since 2000)CEO1999
- Pyrosequencing (Biotage since 2003)CEO1997 — 1998
Skills & more
Lifesciences24Venture Capital36Biotechnology23Clinical Development13Entrepreneurship14Drug Discovery6Pharmaceutical Industry18Corporate Development7Start-ups69Private Equity8Drug Development23Mergers
+3 more
Clinical TrialsBusiness StrategyCommercializationFrom Eugen's professional profile.
Deals · 1
NephroGenexBoard seat
via HealthCap · filed Nov 2015 · $28.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
Network4
Alex Valcu
Partner at HealthCap
Anki Forsberg
Partner and Chairman at HealthCap
Björn Odlander
Managing Partner at HealthCap
Carl Kilander
Partner at HealthCap
Investors connected to Eugen in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Eugen Steiner?
- Venture partner since 1997 who serves as CEO of several portfolio companies. He holds an MD and PhD in clinical pharmacology from Karolinska Institute.
- Where does Eugen Steiner work?
- Eugen Steiner is Board director at NephroGenex.
- What check size does Eugen Steiner write?
- Eugen Steiner typically writes checks of $100K – $5M.
- What boards does Eugen Steiner sit on?
- Eugen Steiner holds tracked board seats at NephroGenex.
- Where did Eugen Steiner go to school?
- Eugen Steiner studied at Karolinska Institutet (Ph.D., Clinical Pharmacology); Karolinska Institutet (M.D.); Weizmann Institute of Science (Summer student).
Same school
Also attended Karolinska Institutet31
Andreas LindblomManaging Partner at ScietyGunnar AhlbergVenture Partner at ScietyJohan LundVenture Partner at ScietyPatrik SobockiPractice Lead Deep Tech and Senior Investment Director at IndustrifondenJonathan IlickiInvestor at IndustrifondenStefan LarssonInvestor at Industrifonden
+ 25 more
